Cangrelor I-1

SL-10232

Cangrelor I-1, >98%

IUPAC Name : ((3aR,4R,6R,6aR)-2-Hydroxy-6-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl)methyl dihydrogen phosphate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an impurity of Cangrelor, which is a potent, selective P2T/P2Y12 receptor antagonist. Cangrelor is used in patients undergoing percutaneous coronary intervention (PCI) to lower the risk of blood clots and heart attack.

References : Flick C. A. et al.: J. Med. Chem., 60(15), 6480-6515, 2017.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.